Contact
Please use this form to send email to PR contact of this press release:
Corbus Pharmaceuticals Announces Initiation of Phase 2 Study of Anabasum for Treatment of Systemic Lupus Erythematosus
TO:
Please use this form to send email to PR contact of this press release:
Corbus Pharmaceuticals Announces Initiation of Phase 2 Study of Anabasum for Treatment of Systemic Lupus Erythematosus
TO: